Gauss

Vkorc1 (human) recombinant (full le nght protein gst tag) 10 µg

Réf. UGAP : 3925784 Réf. Fournisseur : 16183983 Réf. Constructeur : H00079001-P01
Vkorc1 (human) recombinant (full le nght protein gst tag) 10 µg
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.

Points clés

Used for AP, Array, ELISA, WB-Re

Vitamin K is essential for blood clotting but must be enzymatically activated. This enzymatically activated form of vitamin K is a reduced form required for the carboxylation of glutamic acid residues in some blood-clotting proteins. The product of this gene encodes the enzyme that is responsible for reducing vitamin K 2,3-epoxide to the enzymatically activated form. Fatal bleeding can be caused by vitamin K deficiency and by the vitamin K antagonist warfarin, and it is the product of this gene that is sensitive to warfarin. In humans, mutations in this gene can be associated with deficiencies in vitamin-K-dependent clotting factors and, in humans and rats, with warfarin resistance. Two pseudogenes have been identified on chromosome 1 and the X chromosome. Two alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq]

En savoir plus

Garantie

Garantie 0 Mois

Description

Used for AP, Array, ELISA, WB-Re

Vitamin K is essential for blood clotting but must be enzymatically activated. This enzymatically activated form of vitamin K is a reduced form required for the carboxylation of glutamic acid residues in some blood-clotting proteins. The product of this gene encodes the enzyme that is responsible for reducing vitamin K 2,3-epoxide to the enzymatically activated form. Fatal bleeding can be caused by vitamin K deficiency and by the vitamin K antagonist warfarin, and it is the product of this gene that is sensitive to warfarin. In humans, mutations in this gene can be associated with deficiencies in vitamin-K-dependent clotting factors and, in humans and rats, with warfarin resistance. Two pseudogenes have been identified on chromosome 1 and the X chromosome. Two alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq]

Caractéristiques

Type d'antibiotique
non
Marque
ABNOVA
Référence distributeur
16183983
Fournisseur
FISHER SCIENTIFIC S.A.S.
Dispositif stérile
non
Marquage CE DIV
non
Code à barre
non
Type d'acide nucléique extrait
non
Origine humaine
non
Sans composant animal
non
Vendu par
10 ug
Délai de péremption à la date de livraison
12 mois
Température de conservation (°C)
-80 °C
Température de transport
carboglace
Soumis à carboglace
oui
Classification REACH
non
Code douanier
38229000
Nomenclature IFPEN
NA.55
Nomenclature DGOS
LD10AOOO
Domaine de recherche
protéomique
Reprise en cas d’erreur client
non
Libellé produit fabricant
10ug vkorc1 (human) recombinant protein (p01)
Nomenclature Nacres
NA.55
Nomenclature IRSN
273
Type de produit
protéine
Nomenclature INSERM
NA.NA55
Type d’application
ELISA, western-Blot
Nomenclature CHU
18.551
Lieu de stockage
France
Lieu de fabrication
Taïwan
Autres caractéristiques
Abnova Human VKORC1 Full-length ORF (NP_076869.1, 1 a.a. - 163 a.a.) Recombinant Protein with GST-tag at N-terminal, Quantity: 10 ug, Format: Liquid, Formulation: 50mM Tris-HCI, 10mM reduced Glutathione, pH-8.0 in the elution buffer., Host Species: W
Nomenclature CEA
SGP01
Nomenclature CNRS
NA55
Matière dangereuse
non
Type d'échantillon
protéine
Quantité
N/A
Type d'enzyme
non
Type de protéine
oui
Référence fabricant
H00079001-P01
Certification
RUO